123 related articles for article (PubMed ID: 1864728)
1. In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72.
Colcher D; Milenic DE; Ferroni P; Roselli M; Schlom J
Int J Rad Appl Instrum B; 1991; 18(4):395-401. PubMed ID: 1864728
[TBL] [Abstract][Full Text] [Related]
2. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
3. CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients.
Gero EJ; Colcher D; Ferroni P; Melsheimer R; Giani S; Schlom J; Kaplan P
J Clin Lab Anal; 1989; 3(6):360-9. PubMed ID: 2614571
[TBL] [Abstract][Full Text] [Related]
4. Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3.
Ferroni P; Milenic DE; Schlom J; Colcher D
J Clin Lab Anal; 1990; 4(6):465-73. PubMed ID: 2283566
[TBL] [Abstract][Full Text] [Related]
5. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
8. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
Sheer DG; Schlom J; Cooper HL
Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
Katari RS; Fernsten PD; Schlom J
Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
[TBL] [Abstract][Full Text] [Related]
10. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
[TBL] [Abstract][Full Text] [Related]
11. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
12. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
Ohuchi N; Simpson JF; Colcher D; Schlom J
Int J Cancer; 1987 Dec; 40(6):726-33. PubMed ID: 2447021
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen.
Divgi CR; Scott AM; McDermott K; Fallone PS; Hilton S; Siler K; Carmichael N; Daghighian F; Finn RD; Cohen AM
Nucl Med Biol; 1994 Jan; 21(1):9-15. PubMed ID: 9234259
[TBL] [Abstract][Full Text] [Related]
15. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomas.
Simpson JF; Primus FJ; Schlom J
Int J Biol Markers; 1991; 6(2):83-90. PubMed ID: 1716293
[TBL] [Abstract][Full Text] [Related]
16. Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma.
Burak WE; Schneebaum S; Kim JA; Arnold MW; Hinkle G; Berens A; Mojzisik C; Martin EW
Surgery; 1995 Jul; 118(1):103-8. PubMed ID: 7604370
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
18. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
[TBL] [Abstract][Full Text] [Related]
19. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.
Paterson AJ; Schlom J; Sears HF; Bennett J; Colcher D
Int J Cancer; 1986 May; 37(5):659-66. PubMed ID: 3699929
[TBL] [Abstract][Full Text] [Related]
20. CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers.
Ferroni P; Szpak C; Greiner JW; Simpson JF; Guadagni F; Johnston WW; Colcher D
Int J Cancer; 1990 Sep; 46(3):445-51. PubMed ID: 2394511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
